October 6, 2024
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05,…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
October 5, 2024
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
— OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in…
October 4, 2024
Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust
Strengthens balance sheet with non-dilutive capital to enable further pipeline development and related strategic prioritiesCAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE…
October 4, 2024
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
CINCINATTI, OH., Oct. 03, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Onconetix,…
October 4, 2024
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and…
October 4, 2024
Helio Genomics Methylation Model Score for Early Cancer Detection Awarded as a Top Abstract for the 2024 San Antonio Liver Cancer Symposium
IRVINE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in…
October 3, 2024
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct.…
October 3, 2024
Oncocyte Signs Leading Transplant Centers in US and Germany
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in…
October 3, 2024
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad LaboratoriesIRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) —…
October 2, 2024
Owkin, AstraZeneca to develop AI gBRCA pre-screen solution for breast cancer
Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, and AstraZeneca, have teamed up to develop an AI-powered tool to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitised pathology slides.